{"database": "openregs", "table": "stock_trades", "rows": [[51834, "Laurel Lee", "L000597", "House", "2024-10-18", "2024-11-21", "HURA", 1498382, "TuHURA Biosciences, Inc. - Common Stock (HURA) [ST] Kintara Therapeutics (KTRA). The note converted into 31,571 common shares of the combined companies following a concurrent reverse stock split. The combined companies are trading under the name TuHURA Biosciences, trading symbol HURA. Any additional information can be obtained on the company's investor relations website.", "ST", "Exchange", "$100,001 - $250,000", "Spouse", null, "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/20026063.pdf", "P", "FL15", "20026063"]], "columns": ["id", "member_name", "bioguide_id", "chamber", "transaction_date", "disclosure_date", "ticker", "cik", "asset_description", "asset_type", "transaction_type", "amount_range", "owner", "comment", "source_url", "filing_type", "state_district", "doc_id"], "primary_keys": ["id"], "primary_key_values": ["51834"], "units": {}, "query_ms": 0.3819649573415518, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}